Salfarm Danmark A/S now introduces Reconcile®, fluoxetine, 8 mg, 16 mg and 32 mg chewable tablets – for dogs.
Reconcile® can be used as an aid in the treatment of separation-related disorders in dogs manifested by destructive and inappropriate behavior (vocalization and inappropriate defecation and/or urination) and only in combination with behavior modification techniques.
Available in packs with 8 mg: 1×30 chewable tablets (Vnr 09 74 13), 16 mg: 1×30 chewable tablets (Vnr 46 86 88), 32 mg: 1×30 chewable tablets (Vnr 48 79 21)
Reconcile® is available from May 2022.
See the SPC and package insert on the product page for Reconcile®
Mandatory text can be seen on the Reconcile® data sheet.
